ClinicalTrials.gov
public full text
Public Domain
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
adultcolorectal-cancerlung-cancernon-small-cell-lung-cancernsclcpancreatic-cancerpancreatic-ductal-adenocarcinomasolid-tumor
This study will assess the safety and efficacy of VS-7375 alone and in combination in patients with advanced solid tumors harboring a KRAS G12D-mutation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- GH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors#1094222
- Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors.#1033641
- KN035 for dMMR/MSI-H Advanced Solid Tumors#981321
- PhI to Solid Tumors and PhII to Locally Advanced or mTNBC#861144
- A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)#1112611
Record · ID 1009508
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive